Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
03/08/1989 | EP0305744A2 Quinoline, naphthyridine and benzoxazine-carboxylic acid derivatives and their use as antibacterial agents |
03/08/1989 | EP0305743A2 Pharmaceutical mixture preparation, its manufacture and use |
03/08/1989 | EP0305470A1 Antiinfective compounds and method of use. |
03/08/1989 | CN1031533A Stable oxapenem-3-carboxylic acids |
03/07/1989 | US4810702 Antibacterial agent for mammal use comprising cephalosporin derivatives as an effective ingredient |
03/07/1989 | US4810634 Pseudorabies virus mutants incapable of producing glycoprotein X |
03/07/1989 | US4810494 Canine parvovirus vaccines |
03/07/1989 | CA1251000A1 Dipeptides, process for the preparation thereof and pharcameutical preparations containing them |
03/07/1989 | CA1250846A1 6-fluoro-1,4-dihydro-4-oxo-7-(4-pyridyl)-1,8- naphthyridine-3 carboxylic acid compounds |
03/02/1989 | DE3827515A1 Pharmazeutische praeparate fuer die topische anwendung Pharmaceutical preparations for topical application |
03/01/1989 | EP0305173A2 Lysocellin solids purification process |
03/01/1989 | EP0305117A2 2',3'-Dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections |
03/01/1989 | EP0305111A2 Cephalosporin compounds, process for their preparation and their pharmaceutical compositions |
03/01/1989 | EP0305086A2 Antibiotic A80577 and process for its production |
03/01/1989 | EP0304889A2 Novel aristeromycin/adenosine derivatives |
03/01/1989 | EP0304786A2 Intranasal vaccination of horses with inactivated microorganisms or antigenic materials |
03/01/1989 | EP0304731A1 Moranoline derivatives |
03/01/1989 | EP0304578A1 Peptide comprising hepatitis B surface antigen |
03/01/1989 | CN1031379A Polypeptide and method for preparing same, kyosuke |
03/01/1989 | CN1031378A Antibiotic compounds |
03/01/1989 | CN1031325A Topically active compositions of double stranded rnas |
02/28/1989 | US4808727 Chemical intermediates for water-soluble salts of parasiticides |
02/28/1989 | US4808724 2-aminothiazolyl-containing β-lactam antibiotics |
02/28/1989 | US4808716 9-(phosponylmethoxyalkyl) adenines, the method of preparation and utilization thereof |
02/28/1989 | US4808711 Cephalosporin derivatives |
02/28/1989 | US4808703 Novel 3-(4'-aminobutylamino) propylaminobleomycin derivatives |
02/28/1989 | US4808614 Treating herpes infections |
02/28/1989 | US4808606 Alkenylazoles, a process for their preparation and their use |
02/28/1989 | US4808585 Solutions of lactic acid salts of piperazinylquinolone- and piperazinyl-azaquinolone-carboxylic acids |
02/28/1989 | US4808584 Quinolinecarboxylic acid derivatives and antibacterial agent containing the same |
02/28/1989 | US4808583 Solutions of lactic acid salts of piperazinylquinolone- and piperazinyl-azaquinolone-carboxylic acids |
02/28/1989 | US4808577 Boric acid or a salt |
02/28/1989 | US4808411 Antibiotic-polymer compositions |
02/28/1989 | US4808410 Pharmaceutical compositions containing dyclonine HC1 and phenol |
02/28/1989 | CA1250700A1 Glycopeptide derivatives |
02/28/1989 | CA1250577A1 Sparsomycin derivatives |
02/28/1989 | CA1250522A1 Skin care compositions |
02/23/1989 | WO1989001519A1 Human mannose binding protein |
02/23/1989 | WO1989001492A1 Novel polypeptide and method for preparing the same |
02/23/1989 | WO1989001486A1 Biologically active bactericidal/permeability-increasing protein fragments |
02/23/1989 | WO1989001339A1 Hyper-immune globulin against hiv |
02/23/1989 | WO1989001338A1 Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome |
02/23/1989 | WO1989001329A1 Antiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infections |
02/23/1989 | WO1989000582A3 Human granulocyte-macrophage colony stimulating factor and muteins thereof |
02/22/1989 | EP0304294A2 Taliscanin and other Aristolactams for treating neurological disorders, Parkinson's disease, Alzheimer disease and impotence |
02/22/1989 | EP0304158A1 Cephalosporins, processes for their preparation and pharmaceutical compositions containing them |
02/22/1989 | EP0304155A2 Cephalosporin compounds, process for their preparation and their pharmaceutical compositions |
02/22/1989 | EP0304087A2 Quinolone and naphthyridine antibacterial agents containing an alpha-amino acid in the side chain of the 7-substituent |
02/22/1989 | EP0304036A2 3-(substituted)propenyl-7-(aminothiazolylacetamido)ceph-3-em-4-carboxylic acids and esters thereof |
02/22/1989 | EP0303692A1 Cloning of lfa-1 |
02/22/1989 | CN1031253A Antibiotic a80577 and process for its prodn. |
02/22/1989 | CN1031233A Antivirotic compound |
02/22/1989 | CN1031184A Medicated compound as well as its pren. and application |
02/21/1989 | US4806654 Hydroxylation, acylation, reduction, purifying, recovering, bactericides, fungicides, antitumor, antileukemic agents |
02/21/1989 | US4806637 6-(Hydroxyethyl)-2-(heterocyclylthio)-penem-3-carboxylates |
02/21/1989 | US4806565 Antifugal tri-yne carbonates |
02/21/1989 | US4806559 Novel substituted hydroxyalkyl-azole antimycotic agents |
02/21/1989 | US4806542 Isohexide pyrimidines triazines, triazoles and imidazoles useful as cytostatic |
02/21/1989 | US4806539 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acids and antibacterial agents containing them |
02/21/1989 | US4806529 Tetracycline activity enhancement |
02/21/1989 | US4806347 Antitumor agents, viricides in humans |
02/21/1989 | CA1250398A1 Tri-tetra- and pentapeptides, their preparation, and pharmaceutical products containing same |
02/21/1989 | CA1250394A1 Polymeric antibacterial compositions |
02/21/1989 | CA1250236A1 Gel-form topical antibiotic compositions |
02/15/1989 | EP0303571A1 Bisphenylyl compounds |
02/15/1989 | EP0303516A2 Topically active compositions of double-stranded RNAs |
02/15/1989 | EP0303471A2 C.12 modified erythromycin A derivatives |
02/15/1989 | EP0303286A1 2-Oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
02/15/1989 | EP0303277A1 Use of ginkgo bilobae extracts in combating inflammatory processes |
02/15/1989 | EP0303223A2 Water-soluble antibiotic composition and water-soluble salts of new cephem compounds |
02/15/1989 | EP0303186A2 Aryl phosphorus derivatives, their preparation and their use |
02/15/1989 | EP0303172A2 Oxyimino-cephalosporins |
02/15/1989 | CN1031085A Method for preparing crystalline cefadroxil monoltydrate |
02/14/1989 | US4804749 Desmycosins |
02/14/1989 | US4804680 Polycyclic ether antibiotic |
02/14/1989 | US4804651 Methods and compositions for the treatment of psoriasis |
02/14/1989 | US4804534 Antibiotic A 42867 and the addition salts thereof |
02/14/1989 | CA1250098A1 Ester derivatives of antibiotic l 17046 |
02/09/1989 | WO1989000805A2 Treatment of infections with tumor necrosis factor |
02/09/1989 | WO1988009181A3 Monoclonal antibodies neutralizing hiv-1 |
02/08/1989 | EP0302836A1 Pharmaceutical compositions for topical use containing miocamycin |
02/08/1989 | EP0302760A2 Antiviral therapy for hepatitis B using 2',3'-dideoxynucleosides |
02/08/1989 | EP0302692A2 Novel process for purification of hepatitis A virions |
02/08/1989 | EP0302525A2 Quinolones as antibacterial agents |
02/08/1989 | EP0302372A1 Naphthyridine antianaerobic compounds |
02/08/1989 | EP0302370A1 Erythromycin formulations for oral administration |
02/08/1989 | EP0302263A2 Therapeutic composition for combatting AIDS |
02/08/1989 | EP0302145A2 Method for preparing crystalline cefadroxil monohydrate |
02/08/1989 | EP0145739B1 Novel antiviral agents |
02/07/1989 | US4803267 Acylation of cephalosporin c |
02/07/1989 | US4803201 Aphidicolane derivatives; viricides; antitumor agents |
02/07/1989 | US4803196 B-lactam antibiotic, base carbon dioxide mixture |
02/07/1989 | US4803074 FR-900848 substance and preparation thereof |
02/07/1989 | US4803066 Antibacterial and/or antifungal compositions for topical application |
02/07/1989 | CA1249817A1 Acridine derivatives |
02/01/1989 | EP0301785A2 Carboxamide derivatives of glycopeptides |
02/01/1989 | EP0301394A1 Stable oxapenem-3-carboxylic acids |
02/01/1989 | EP0301257A2 Cephem Derivatives and a process for their manufacture |
02/01/1989 | EP0301247A2 De-mannosyl teicoplanin derivatives |
02/01/1989 | EP0301206A2 Use of azidothymidine in the treatment of psoriasis |